Ganglioneuroma is a benign tumor with slow growth that originates from nerve cells, including sympathetic ganglia. This tumor is composed of ganglion cells, neurons, Schwann cells, and fibrous tissue (
12). Ganglioneuroma is usually asymptomatic; however, in cases where the tumor is large, retroperitoneal ganglioneuroma can cause the abdominal pain, palpation of the mass during abdominal examination, and compressive effects on the surrounding organs (
9). This tumor is typically non-secreting, but in some cases, it can cause the secretion of substances such as catecholamines, leading to a hypertensive crisis during surgery (
10).
In a study by Nugraha and Hernowo a case of mediastinal ganglioneuroma was reported in a 3-year-old child who presented with shortness of breath (
1). Kizildag et al. reported a 19-year-old female with ganglioneuroma of the right posterior mediastinum. She presented with lower back pain and dyspnea (
13).
In the study by Haghighi et al., a five-year-old boy with retroperitoneal ganglioneuroma complained of abdominal pain (
9). Additionally, Singh et al. reported a case of retroperitoneal ganglioneuroma in a patient who presented with painless swelling in the left upper abdomen (
8).
Among the various imaging methods for detecting abdominal and retroperitoneal masses, CT scan and MRI are considered the most effective. In sonography, the lesion typically appears as a homogeneous and hypoechoic mass (
14). While the visual appearance of ganglioneuroma may not be as distinctive in MRI as it is in CT scans (
15), in our case, a heterogeneous hypodense mass measuring approximately 135 × 105 mm was observed in the left upper region based on abdominal and pelvic CT scans. Singh et al. also utilized CT scan and sonography to diagnose ganglioneuroma, with the ultrasound scan revealing a hypoechoic ganglioneuroma and the CT scan showing a hypodense lobular mass (
8). Similarly, in the case described in Haghighi's study, the retroperitoneal mass was diagnosed using CT scan and sonography (
9).
CT scan is commonly employed for evaluating tumors, as it can show the extent of the tumor, regional invasion, vascular encasement, adenopathy, and calcification (
2).
According to studies, over 30% of patients with ganglioneuroma experience an increase in urinary and plasma catecholamines, but only a few exhibit symptoms of this elevation in vasoactive amines (
1), which was not the case with our patients. Similar to our situation, studies by Paasch et al. and Haghighi et al. did not report any increases in catecholamines (
5,
9).
However, some patients with ganglioneuroma do have higher levels of catecholamines, such as vanillylmandelic acid or homovanillic acid (
2). For a definitive diagnosis of ganglioneuroma, needle aspiration is typically used (
2). Similar to the study by Haghighi et al. (
9), needle aspiration was also used for the definitive diagnosis in our case. Surgical removal of the tumor is the standard treatment for ganglioneuroma, if possible. Chemotherapy or radiation therapy before or after surgery is usually unnecessary unless ganglioneuroma is associated with ganglioneuroblastoma subtypes (
8). The prognosis for ganglioneuroma is generally good, as it rarely becomes malignant or spreads. While local recurrence is uncommon, it is still recommended to undergo radiologic surveillance after resection (
1).
In the case reported by Haghighi et al., definitive treatment was performed with laparotomy surgery, and a definitive diagnosis was also made through pathology. During follow-up, there were no signs of tumor recurrence (
9). Additionally, Paasch et al. utilized the laparotomy method to treat a patient with retroperitoneal ganglioneuroma (
5).
Ganglioneuroma is a benign tumor originating from ganglion cells, typically found in the posterior mediastinum and retroperitoneal area. It is often asymptomatic. This report details a patient presenting with shortness of breath who was diagnosed with mediastinal ganglioneuroma. The preferred treatment for ganglioneuroma is surgical removal of the mass. Following complete removal, chemotherapy and radiotherapy are not typically necessary. This study underscores the importance of imaging in evaluating ganglioneuroma as a posterior mediastinal tumor.